Format

Send to

Choose Destination
See comment in PubMed Commons below
Dev Biol. 2015 Dec 15;408(2):196-204. doi: 10.1016/j.ydbio.2015.11.003. Epub 2015 Nov 4.

CRISPR/Cas9: An inexpensive, efficient loss of function tool to screen human disease genes in Xenopus.

Author information

1
Departments of Genetics and Pediatrics, Yale University School of Medicine, New Haven, CT 06520, United States.
2
Departments of Genetics and Pediatrics, Yale University School of Medicine, New Haven, CT 06520, United States. Electronic address: Mustafa.khokha@yale.edu.

Abstract

Congenital malformations are the major cause of infant mortality in the US and Europe. Due to rapid advances in human genomics, we can now efficiently identify sequence variants that may cause disease in these patients. However, establishing disease causality remains a challenge. Additionally, in the case of congenital heart disease, many of the identified candidate genes are either novel to embryonic development or have no known function. Therefore, there is a pressing need to develop inexpensive and efficient technologies to screen these candidate genes for disease phenocopy in model systems and to perform functional studies to uncover their role in development. For this purpose, we sought to test F0 CRISPR based gene editing as a loss of function strategy for disease phenocopy in the frog model organism, Xenopus tropicalis. We demonstrate that the CRISPR/Cas9 system can efficiently modify both alleles in the F0 generation within a few hours post fertilization, recapitulating even early disease phenotypes that are highly similar to knockdowns from morpholino oligos (MOs) in nearly all cases tested. We find that injecting Cas9 protein is dramatically more efficacious and less toxic than cas9 mRNA. We conclude that CRISPR based F0 gene modification in X. tropicalis is efficient and cost effective and readily recapitulates disease and MO phenotypes.

KEYWORDS:

CRISPR; Cas9 protein; Fragment analysis; Morpholino; Xenopus tropicalis; beta-catenin; ccdc40; dnah9; foxj1; pax8; tyrosinase

PMID:
26546975
PMCID:
PMC4684459
DOI:
10.1016/j.ydbio.2015.11.003
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center